RxDoctor Payments Data

Rachel Tryba, PA

Physician Assistant · Easthampton, MANPI 1013550110

Payments from drug & device makers

$2,006in general payments, 2019–2025

Across 103 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$382
  • GSK$309
  • Lundbeck LLC$282
  • Abbott$223
  • Exact Sciences$164
  • Novo Nordisk$162
  • plus $483 from 7 others

What the payments were for

  • Food & beverage$2,006100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,006 in reported general payments places this provider in the 90th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$4,703
Medicare patients
37
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban171$133,026
OzempicSemaglutide91$83,509
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$48,905
JanuviaSitagliptin Phosphate27$35,670
TrulicityDulaglutide26$32,554
MounjaroTirzepatide31$31,946
CreonLipase/Protease/Amylase11$25,521
Breo ElliptaFluticasone/Vilanterol56$22,946
XareltoRivaroxaban20$16,685
Tresiba Flextouch U-200Insulin Degludec12$8,847
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$4,623
Atorvastatin Calcium236$4,353
Rosuvastatin Calcium67$3,324
NovologInsulin Aspart12$3,169
Omeprazole189$3,099

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$98$133,026171 claims
Novo NordiskOzempic, Novolog$162$86,678103 claims
GSKTrelegy Ellipta, Breo Ellipta$309$71,851131 claims
Lilly USA, LLCTrulicity, Mounjaro$382$64,50057 claims
AbbVieCreon, Synthroid$37$27,95558 claims
Johnson & JohnsonXarelto$159$16,68520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Easthampton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →